Ann: Commercial start of cannaQIX in BENELUX with first orders, page-2

Highlights:
• Creso Pharma signs a commercial agreement with Mediphos OTC Consumer Health BV Netherlands for the marketing and distribution of its unique CBD human health nutraceutical product cannaQIX® in the Benelux
• First purchase order with a value of 40,000 CHF (A$53,277) has been placed concurrent with the signing of the agreement
• The agreement follows the approval by KOAG/KAG, The Dutch Council for Monitoring of health products, to market cannaQIX® in the Netherlands
• The launch and distribution of cannaQIX® is planned for Q3 2018 in the Netherlands


I am not going to complain about this.. it is a start, and lets hope there are follow up orders.